Proteome Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Proteome Sciences generated cash of -$481,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,062,000 last year. Net change in cash is therefore -$1,967,000.
Cash Flow
| 2014 | -6.26B | 8.42B | -5.12B |
|---|---|---|---|
| 2015 | 46.63B | -6.55B | -33.69B |
| 2016 | -31.69B | 36.70B | 42.06B |
| 2017 | 55.47B | 3.50B | 6.3B |
| 2018 | -14.78B | 1.24B | 17.18B |
| 2019 | -21.45B | -23.96B | 21.63B |
| 2020 | -7.74B | -18.37B | 67.98B |
| 2021 | 10.52B | 4.27B | 38.50B |
| 2022 | 3.88B | -21.67B | 27.04B |
| 2023 | -481K | -424K | -1.06M |
PRM.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.99M | 259.20B | 210.14B | 166.61B | 193.73B | 204.61B | 144.11B | 86.55B | 78.47B | 81.75B |
Operating activities | ||||||||||
Net income | -2.44M | 5.92B | 7.00B | 2.38B | 3.27B | 2.34B | -1.10B | 2.08B | -49M | 76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 484K | 727M | 1.67B | 1.54B | 1.48B | 1.25B | 583M | 1.16B | 1.06B | 955M |
Stock-based compensation expense | 218K | 303K | 570K | 8K | 83K | 29K | 67K | 34K | 35K | 181.48K |
| Deferred income tax benefit | 218K | 303K | 570K | 8K | 83K | 29K | 67K | 34K | 35K | 181.48K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 704K | -920K | 163K | 571K | -1.16M | 77K | -63K | -183K | -233K | 0 |
Inventories | 63K | 187K | -211K | -6K | 276K | -201K | -346K | -309K | 54K | 58.12K |
Accounts payable | -298K | 293K | -287K | 158K | 197K | 6K | 118K | -144K | 258K | 0 |
Cash generated by operating activities | -481K | 3.88B | 10.52B | -7.74B | -21.45B | -14.78B | 55.47B | -31.69B | 46.63B | -6.26B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -237K | -1.74B | -1.72B | -1.32B | -1.79B | -1.40B | -1.45B | -1.70B | -1.92B | -691M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -424K | -21.67B | 4.27B | -18.37B | -23.96B | 1.24B | 3.50B | 36.70B | -6.55B | 8.42B |
Financing activities | ||||||||||
Common Stock Issued | 13.74B | 13.14B | 9.95B | 4.67B | 6.32B | 7.31B | 23K | 3.12M | 2.38M | 4.79M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -5.24B | -4.13B | -1.67B | -1.41B | -3.07B | -4.06B | 0 | -1.72B | 0 | -909M |
Repayments of term debt | -824K | -209K | -8.28B | -3.25B | -58K | -3.24B | -220K | -1.14B | -55K | -869M |
Cash used in financing activities | -1.06M | 27.04B | 38.50B | 67.98B | 21.63B | 17.18B | 6.3B | 42.06B | -33.69B | -5.12B |
Net Change In Cash | -1.96M | 19.58B | 49.06B | 43.52B | -27.12B | -10.87B | 60.50B | 57.55B | 8.07B | -3.27B |
Cash at end of period | 2.02M | 278.79B | 259.20B | 210.14B | 166.61B | 193.73B | 204.61B | 144.11B | 86.55B | 78.47B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |